2023 Speaking Faculty
The FULL speaking faculty for this event has not yet been announced. Please check back in the coming days for updates or join our mailing list.
Joshua Woolley, MD, Ph.D.Associate Professor, Psychiatry
UCSF Weill Institute for Neurosciences
Gul Dolen, MD, Ph.D.Associate Professor of Neuroscience, Brain Institute, Wendy Klag Center
Johns Hopkins University
Jaspreet GrewalChief Executive Officer & Co-Founder
Knowde Group
Bryan Roth, MD, Ph.D.Michael Hooker Distinguished Prof., Pharmacology, Dir., NIMH Psychoactive Drug Screening Program, Eshelman School of Pharmacy
Univ. of North Carolina Chapel Hill
Tim SchlidtCo-founder & Partner
Palo Santo
Boris Heifets, MD, Ph.D.Assistant Professor of Anesthesiology, Perioperative & Pain Medicine
Stanford University
Karen Luong, JDSenior Counsel
Husch Blackwell
Christopher KoddermannCo-Founder & Chair of the Board
International Therapeutics Psilocybin Rescheduling Initiative
Natalie Gukasyan, MDAssistant Prof., Dept. of Psychiatry & Behavioral Sciences, Medical Dir., Center for Psychedelic & Consciousness Research
Johns Hopkins University School of Medicine
James Kuo, MD, MBAVice President of R&D
Silo Pharma
Sabrina Ramkellawan, CCRP, CCRAChief Operating Officer & Co-Founder
Knowde Group
Gitte Knudsen, MD, DMScProfessor, Chair of Neurobiology Research Unit, Rigshospitalet, Chair of Center for Experimental Medicine Neuropharmacology
University of Copenhagen
Kimberly Chew, JDSenior Counsel
Husch Blackwell
Tom McDonaldChief Executive Officer
Clerkenwell Health
Manesh GirnPhD Candidate (Neuroscience), Laboratory of Brain and Cognition, Montreal Neurological Institute
McGill University
Matthew Baggott, Ph.D.Co-founder & Chief Executive Officer
Tactogen
Laszlo Kiss, Ph.D.CBO and Head of Research
Gilgamesh Pharmaceuticals
Sandeep Nayak, MDAssistant Professor, Department of Psychiatry & Behavioral Sciences, Behavioral Pharmacology Research Unit
Johns Hopkins Center for Psychedelic and Consciousness Research
Natasha Sumner, JDSenior Counsel
Husch Blackwell
Elliot Marseille, DrPH, MPPDirector
UC Berkeley/UCSF Global Initiative for Psychedelic Science Economics
Principal
Health Strategies International
Hailey Gilmore, MPHMedical Affairs Program Manager
MAPS Public Benefit Corporation
The FULL speaking faculty for this event has not yet been announced. Please check back in the coming days for updates or join our mailing list.
